«
Back to Press Releases & Article Home
Cipla to market Generic
Tamiflu
Cipla got marketing approval
for Anti-Flu from drug controller-general of India. Cipla
will launch...
Distribution Source : Finegenerics
Date : Wednesday, February 15, 2006
Cipla got marketing approval for Anti-Flu
from drug controller-general of India. Cipla will launch a
generic version of bird flu drug, Oseltamivir,
in the domestic market this month. The drug would be priced
at about Rs 1,000 per strip of 10 pills.
“Cipla plans to sell the product in
49 countries where the patent is not applicable,” company
sources said.
Each tablet of Anti-Flu
will contain 75 mg of the wonder formula. Two tablets consumed
everyday over five days will stop the flu from dispersal.
The company plans to sell the drug at less than half the market
price. At present, 10 tablets of Tamiflu
sell for $60.
"We have received four export orders,
the first one of which will leave by the end of this month."
Cipla's joint MD Amar Lulla told TOI.
Sources also added that “The risk of
the disease in India and other poor countries is very high.
So, we decided to go ahead with manufacturing and marketing
of this product in India, where Roche or Gilead are yet to
receive the patent.”
This news release is
entirely a personal opinion. It should not be misconstrued
as a medical advice.
-----------------------------------------------------------------------------
|
Bird
Flu cases in Indonesia and Japan
Thursday, 13
Apr. 2006
Avian flu is any flu
caused by a virus adapted to birds. It is also
called bird flu, avian influenza and bird influenza...
Generic
drugs in high demand Friday,
24 Mar. 2006
Generic drugs have
emerged as a good alternative to branded drugs.
People can use the drug with the same effect as
compared to any other branded drug...
|
|
|
